{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T23:06:21Z","timestamp":1776985581271,"version":"3.51.4"},"reference-count":24,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.bbrc.2015.01.026","type":"journal-article","created":{"date-parts":[[2015,1,17]],"date-time":"2015-01-17T07:01:28Z","timestamp":1421478088000},"page":"572-577","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Type II anti-CD20 mAb-induced lysosome mediated cell death is mediated through a ceramide-dependent pathway"],"prefix":"10.1016","volume":"457","author":[{"given":"Hua","family":"Ren","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liwei","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Bi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2015.01.026_bib1","first-page":"2143","article-title":"Monoclonal antibodies directed to CD20 and HLA-DR can elicit homotypic adhesion followed by lysosome-mediated cell death in human lymphoma and leukemia cells","volume":"119","author":"Ivanov","year":"2009","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.bbrc.2015.01.026_bib2","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/S0140-6736(12)60605-9","article-title":"Non-Hodgkin lymphoma","volume":"380","author":"Shankland","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.bbrc.2015.01.026_bib3","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1186\/1556-276X-9-447","article-title":"Potentiating antilymphoma efficacy of chemotherapy using a liposome for integration of CD20 targeting, ultra-violet irradiation polymerizing, and controlled drug delivery","volume":"9","author":"Wu","year":"2014","journal-title":"Nanoscale Res. Lett."},{"key":"10.1016\/j.bbrc.2015.01.026_bib4","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.1182\/blood-2011-12-395541","article-title":"Antibody-induced nonapoptotic cell death in human lymphoma and leukemia cells is mediated through a novel reactive oxygen species-dependent pathway","volume":"119","author":"Honeychurch","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2015.01.026_bib5","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S1470-2045(07)70106-7","article-title":"Addition of fresh frozen plasma as a source of complement to rituximab in advanced chronic lymphocytic leukaemia","volume":"8","author":"Klepfish","year":"2007","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bbrc.2015.01.026_bib6","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.coi.2008.05.011","article-title":"Immunotherapeutic mechanisms of anti-CD20 monoclonal antibodies","volume":"20","author":"Taylor","year":"2008","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.bbrc.2015.01.026_bib7","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1200\/JCO.2012.46.9718","article-title":"Obinutuzumab (GA101) in patients with relapsed\/refractory indolent non-Hodgkin lymphoma: results from the phase II GAUGUIN study","volume":"31","author":"Salles","year":"2013","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.bbrc.2015.01.026_bib8","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.3109\/10428194.2013.856008","article-title":"Enhanced anti-tumor activity of the glycoengineered type II CD20 antibody obinutuzumab (GA101) in combination with chemotherapy in xenograft models of human lymphoma","volume":"55","author":"Herting","year":"2014","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.bbrc.2015.01.026_bib9","doi-asserted-by":"crossref","first-page":"4170","DOI":"10.1182\/blood-2008-04-149161","article-title":"Type II (tositumomab) anti-CD20 monoclonal antibody out performs type I (rituximab-like) reagents in B-cell depletion regardless of complement activation","volume":"112","author":"Beers","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2015.01.026_bib10","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1053\/j.seminhematol.2010.01.007","article-title":"CD20-targeted therapy: the next generation of antibodies","volume":"47","author":"van Meerten","year":"2010","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.bbrc.2015.01.026_bib11","doi-asserted-by":"crossref","first-page":"4519","DOI":"10.1182\/blood-2010-07-296913","article-title":"Novel type II anti-CD20 monoclonal antibody (GA101) evokes homotypic adhesion and actin-dependent, lysosome-mediated cell death in B-cell malignancies","volume":"117","author":"Alduaij","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2015.01.026_bib12","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0092-8674(94)90147-3","article-title":"The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling","volume":"77","author":"Kolesnick","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2015.01.026_bib13","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.1128\/MCB.00121-12","article-title":"Regulation of cell migration by sphingomyelin synthases: sphingomyelin in lipid rafts decreases responsiveness to signaling by the CXCL12\/CXCR4 pathway","volume":"32","author":"Asano","year":"2012","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbrc.2015.01.026_bib14","doi-asserted-by":"crossref","first-page":"26509","DOI":"10.1074\/jbc.M801597200","article-title":"Ceramide generated by sphingomyelin hydrolysis and the salvage pathway is involved in hypoxia\/reoxygenation-induced Bax redistribution to mitochondria in NT-2 cells","volume":"283","author":"Jin","year":"2008","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2015.01.026_bib15","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s00280-013-2318-3","article-title":"Bortezomib-induced apoptosis in cultured pancreatic cancer cells is associated with ceramide production","volume":"73","author":"Gong","year":"2014","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.bbrc.2015.01.026_bib16","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1471-2407-14-24","article-title":"Ceramide targets xIAP and cIAP1 to sensitize metastatic colon and breast cancer cells to apoptosis induction to suppress tumor progression","volume":"14","author":"Paschall","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbrc.2015.01.026_bib17","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/cdd.2014.128","article-title":"Stress-induced ceramide generation and apoptosis via the phosphorylation and activation of nSMase1 by JNK signaling","volume":"22","author":"Yabu","year":"2015","journal-title":"Cell. Death Differ."},{"key":"10.1016\/j.bbrc.2015.01.026_bib18","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.theriogenology.2013.04.016","article-title":"Sphingosine-1-phosphate inhibits ceramide-induced apoptosis during murine preimplantation embryonic development","volume":"80","author":"Guo","year":"2013","journal-title":"Theriogenology"},{"key":"10.1016\/j.bbrc.2015.01.026_bib19","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S1388-1981(02)00335-9","article-title":"Serine palmitoyltransferase: role in apoptotic de novo ceramide synthesis and other stress responses","volume":"1585","author":"Perry","year":"2002","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbrc.2015.01.026_bib20","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.jnutbio.2014.07.008","article-title":"Involvement of de novo ceramide synthesis in pro-inflammatory adipokine secretion and adipocyte-macrophage interaction","volume":"25","author":"Hamada","year":"2014","journal-title":"J.\u00a0Nutr. Biochem."},{"key":"10.1016\/j.bbrc.2015.01.026_bib21","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0167-4889(98)00112-8","article-title":"Tumor necrosis factor-alpha-induced release of plasminogen activator inhibitor-1 from human umbilical vein endothelial cells: involvement of intracellular ceramide signaling event","volume":"1448","author":"Soeda","year":"1998","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbrc.2015.01.026_bib22","doi-asserted-by":"crossref","first-page":"27299","DOI":"10.1016\/S0021-9258(19)74249-5","article-title":"Fumonisin B1 inhibits sphingosine (sphinganine) N-acyltransferase and de novo sphingolipid biosynthesis in cultured neurons in situ","volume":"268","author":"Merrill","year":"1993","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2015.01.026_bib23","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1182\/blood-2014-07-586610","article-title":"Obinutuzumab (GA101) in relapsed\/refractory chronic lymphocytic leukemia: final data from the phase 1\/2 GAUGUIN study","volume":"124","author":"Cartron","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2015.01.026_bib24","doi-asserted-by":"crossref","first-page":"5191","DOI":"10.1182\/blood-2010-01-263533","article-title":"Antigenic modulation limits the efficacy of anti-CD20 antibodies: implications for antibody selection","volume":"115","author":"Beers","year":"2010","journal-title":"Blood"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X15000480?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X15000480?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,26]],"date-time":"2022-04-26T23:19:33Z","timestamp":1651015173000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X15000480"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S0006291X15000480"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2015.01.026","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Type II anti-CD20 mAb-induced lysosome mediated cell death is mediated through a ceramide-dependent pathway","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2015.01.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}